Vancouver-based health care company Numinus Bioscience has officially harvested the first legal batch of Psilocybe mushrooms in Canada by a public company. The announcement came only a few months after the company amended its Health Canada-issued Controlled Drugs and Substances Dealer’s Licence to allow researchers to conduct research to standardize the extraction of psilocybin from mushrooms. The license also permits the company to test, import and export, store, and distribute MDMA, Psilocybin, Psilocin, DMT, and Mescaline.

Numinus Bioscience first Psilocybe Cubensis harvest

A natural source of high-quality psilocybin is of great benefit to both researchers and potential patients of the developing form of medicine. Natural psilocybin extracts are likely to be far more affordable compared to their synthetic counterparts. With its new supply, Numinus seeks to develop safe, evidence-based, accessible psychedelic-assisted psychotherapy through extensive research and development.

Numinus Bioscience first Psilocybe Cubensis harvest

The company has also announced it’s seeking to amend its Controlled Drugs and Substances Licence to permit the sale of Psilocybe mushroom fruiting bodies and extracts for clinical research elsewhere. The first harvest has been a huge positive milestone for the industry, whose focus now lies in research.

Do you support the research of psychedelic-assisted psychotherapy? Let us know in the comments below!